Gabaergic Drugs in the Treatment of Epilepsy: Modern or Outmoded?
Author:
- 11 February 2011
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 3 (2) , 177-182
Abstract
Antiepileptic drugs have a number of mechanisms of action that target brain excitability systems. The potentiation of GABAergic inhibitory neurotransmission represents a classic and well-known antiseizure effect. Currently available GABAergic antiepileptic drugs mainly target GABA(A) receptor-associated complexes, GABA reuptake or GABA catabolism. All these compounds, although generally effective, are limited by their deleterious effects on cognition and behavior. The challenge will be to find GABAergic drugs that exhibit the beneficial effects, without the adverse ones.Keywords
This publication has 48 references indexed in Scilit:
- Insights into the Structure and Pharmacology of GABAAReceptorsFuture Medicinal Chemistry, 2010
- Anticonvulsant, antiepileptogenic, and antiictogenic pharmacostrategiesCellular and Molecular Life Sciences, 2007
- Molecular Targets for Antiepileptic Drug DevelopmentNeurotherapeutics, 2007
- Adult epilepsyThe Lancet, 2006
- Variations on an inhibitory theme: phasic and tonic activation of GABAA receptorsNature Reviews Neuroscience, 2005
- Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric PatientsJournal of Child Neurology, 2004
- The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditionsNature Medicine, 2004
- The neurobiology of antiepileptic drugsNature Reviews Neuroscience, 2004
- Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-containing GABA A receptorsProceedings of the National Academy of Sciences, 2003
- The GABA-A receptor gene family: new targets for therapeutic interventionNeurochemistry International, 1999